Laughter therapy and pursed-lip breathing exercises can reduce dyspnea severity and improve overall health status among patients with COPD.

Arrhythmia-related mortality in patients with congenital heart disease declined overall between 1999 and 2024 despite a recent upward trend.

More advanced cardiovascular-kidney-metabolic syndrome among young adults is associated with worse cardiovascular health.

Integrating machine learning with clinical red flags may help in the diagnosis of patients with suspected hereditary ATTR.

By 2049, global type 1 diabetes incident cases are expected to reach 605,058 cases per year based on current statistics and projections.

Quantitative SPECT/CT utilizing SUV-based metrics provides a sensitive, reproducible assessment of tafamidis treatment response in ATTR-CM, a study shows.

A new machine learning algorithm can use facial videos to detect diabetes and hypertension without more invasive sampling techniques.

For patients with obesity and primary aldosteronism, there is a link to a higher cardiometabolic burden and poorer clinical response to targeted treatments.

The phase 3 Lp(a)HORIZON trial found that while pelacarsen lowered Lp(a) levels, it did not reduce major cardiovascular events in patients with established CVD.

A new algorithm appears to identify hypertension, ischemic heart disease, and cerebrovascular accidents during routine mammography.

Rusfertide receives FDA approval as a polycythemia vera treatment for adults who do not achieve adequate control through existing therapies.

Adults aged 40 years and older with symptoms of cognitive impairment may now qualify for a recently approved blood test for Alzheimer disease.